PT - JOURNAL ARTICLE AU - Li, Mengyuan AU - Zhang, Zhilan AU - Cao, Wenxiu AU - Liu, Yijing AU - Du, Beibei AU - Chen, Canping AU - Liu, Qian AU - Uddin, Md. Nazim AU - Jiang, Shanmei AU - Chen, Cai AU - Zhang, Yue AU - Wang, Xiaosheng TI - Identifying novel factors associated with COVID-19 transmission and fatality using the machine learning approach AID - 10.1101/2020.06.10.20127472 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.10.20127472 4099 - http://medrxiv.org/content/early/2020/06/12/2020.06.10.20127472.short 4100 - http://medrxiv.org/content/early/2020/06/12/2020.06.10.20127472.full AB - The COVID-19 virus has infected millions of people and resulted in hundreds of thousands of deaths worldwide. By using the logistic regression model, we identified novel critical factors associated with COVID19 cases, death, and case fatality rates in 154 countries and in the 50 U.S. states. Among numerous factors associated with COVID-19 risk, we found that the unitary state system was counter-intuitively positively associated with increased COVID-19 cases and deaths. Blood type B was a protective factor for COVID-19 risk, while blood type A was a risk factor. The prevalence of HIV, influenza and pneumonia, and chronic lower respiratory diseases was associated with reduced COVID-19 risk. Obesity and the condition of unimproved water sources were associated with increased COVID-19 risk. Other factors included temperature, humidity, social distancing, smoking, and vitamin D intake. Our comprehensive identification of the factors affecting COVID-19 transmission and fatality may provide new insights into the COVID-19 pandemic and advise effective strategies for preventing and migrating COVID-19 spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the China Pharmaceutical University (grant numbers 3150120001 to XW).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are available.SARS-CoV-22019 novel coronavirusCFRscase fatality ratesBMIbody mass indexρcorrelation coefficientAUCthe area under the receiver operating characteristic curveCVcross validation.